NMPA Approval

Lopinavir and Ritonavir Tablets

Approval Number

国药准字HJ20170213

Registration Date

December 20, 2021

Previous Approval Numbers

H20170213

Drug Information

Generic Name

洛匹那韦利托那韦片

Trade Name

克力芝

Brand Name

克力芝

Dosage Form

片剂

Strength

每片含洛匹那韦200mg，利托那韦50mg

Drug Type

化学药品

Registration Date

December 20, 2021

Expiry Date

December 19, 2026

Company Address

Knollstrasse 67061 Ludwigshafen,Germany

Company Address

Knollstrasse 67061 Ludwigshafen,Germany

Empowering clinical research with data-driven insights and AI-powered tools.

洛匹那韦利托那韦片 - NMPA 批准文号 | MedPath